StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis Tafinlar + Mekinist Global Growth in Constant Currencies by Quarter

Tafinlar + Mekinist Global Growth in Constant Currencies (% cc) (%)

QuarterlyAnnual

Novartis Tafinlar + Mekinist Global Growth in Constant Currencies: 4.0% in Q3 2026, up 3.0 pts from a year earlier.

Latest, Q3 2026
4.0%
Period ended Sep 30, 2026
Change on a year earlier
+3.0 pts
1.0% in Q3 2025
History
27 quarters
Since Q4 2018
Sources
27
Documents cited below

Where the Q3 2026 figure comes from

“|| Tafinlar + Mekinist | 570 | 550 | 4 | 4”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTafinlar + Mekinist Global Growth in Constant Currencies (% cc) (%)Year on yearSource
Q3 2026Sep 30, 20264.0%+3.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20260.0%-7.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-14.0%-33.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025-2.0%-12.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20251.0%-11.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 20257.0%-2.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202519.0%+14.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202410.0%+3.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202412.0%+4.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 20249.0%-4.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 20245.0%-13.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 20237.0%-1.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 20238.0%-8.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202313.0%–Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 202318.0%–Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 20228.0%–Novartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis Tafinlar + Mekinist Global Growth in Constant Currencies (%), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-tafinlar-mekinist-yoy-cc-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.